Is IOVA undervalued or overvalued?

As of 2025-03-20, the Intrinsic Value of Iovance Biotherapeutics Inc (IOVA) is 11.95 USD. This IOVA valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 3.56 USD, the upside of Iovance Biotherapeutics Inc is 235.70%. This means that IOVA is undervalued by 235.70%.

The range of the Intrinsic Value is 9.99 - 14.12 USD

	Range	Selected	Upside
a
DCF (Growth 5y)	(102.55) - (33.83)	(48.89)	-1473.2%
DCF (Growth 10y)	(26.95) - (68.04)	(36.11)	-1114.4%
DCF (EBITDA 5y)	9.99 - 14.12	11.95	235.7%
DCF (EBITDA 10y)	5.85 - 12.86	9.03	153.7%
Fair Value	-5.68 - -5.68	-5.68	-259.42%
P/E	(19.71) - (27.13)	(19.58)	-650.0%
EV/EBITDA	(15.72) - (13.08)	(15.70)	-540.9%
EPV	(17.25) - (24.51)	(20.88)	-686.4%
DDM - Stable	(11.83) - (54.43)	(33.13)	-1030.7%
DDM - Multi	(8.72) - (32.08)	(13.82)	-488.2%